4.5 Review

p21-Activated Kinases in Thyroid Cancer

期刊

ENDOCRINOLOGY
卷 161, 期 8, 页码 -

出版社

ENDOCRINE SOC
DOI: 10.1210/endocr/bqaa105

关键词

cancer; thyroid cancer; PAK; p21-activated kinase; BRAF; signaling

资金

  1. National Institutes of Health [R01CA102572, R01CA227847]

向作者/读者索取更多资源

The family of p21-activated kinases (PAKs) are oncogenic proteins that regulate critical cellular functions. PAKs play central signaling roles in the integrin/CDC42/Rho, ERK/MAPK, PI3K/AKT, NF-kappa B, and Wnt/beta-catenin pathways, functioning both as kinases and scaffolds to regulate cell motility, mitosis and proliferation, cytoskeletal rearrangement, and other cellular activities. PAKs have been implicated in both the development and progression of a wide range of cancers, including breast cancer, pancreatic melanoma, thyroid cancer, and others. Here we will discuss the current knowledge on the structure and biological functions of both group I and group II PAKs, as well as the roles that PAKs play in oncogenesis and progression, with a focus on thyroid cancer and emerging data regarding BRAF/PAK signaling.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据